NCT04839042View on ClinicalTrials.gov

A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

June 28, 2021

Primary Completion Date

March 4, 2025

Study Completion Date

March 4, 2025

Conditions
Covid19
Interventions
BIOLOGICAL

SC-Ad6-1

SC-Ad6-1, I.M., single or multiple-dose

BIOLOGICAL

SC-Ad6-1

SC-Ad6-1, I.N., single or multiple-dose

BIOLOGICAL

SC-Ad6-1

SC-Ad6-1, I.H., single or multiple-dose

Trial Locations (1)

Unknown

Tetherex Study Site, Brisbane

Sponsors
All Listed Sponsors
lead

Moat Biotechnology Corporation

INDUSTRY

NCT04839042 - A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers | Biotech Hunter | Biotech Hunter